Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,020.88
+16.530.82%
Number of Gainers:615
Number of Losers:390
Number of Flat:16
PE:- -
High:2,028.19
Open:2,004.58
Low:2,004.58
Close:2,004.35
Volume:6.06B
Turnover:742.41B
Market Cap:96.59T
Float Cap:90.42T

Loading ...

Sony, UMG sue Suno, accusing it of ‘model laundering,’ Verge says

TIPRANKS
·
Sep 26

RES boosts treasury share holdings as it strengthens circular economy footprint

TIPRANKS
·
Sep 26

SBE-Varvit Lifts First-Half Revenues and Profit, Targets Higher Margins for 2026

TIPRANKS
·
Sep 26

Meta Platforms' Muse Shows Early Momentum, Monetization Remains Unclear, Oppenheimer Says

MT Newswires Live
·
Sep 26

OVS Publishes Half-Year Financial Report for July 31, 2026

TIPRANKS
·
Sep 26

Neodecortech Lifts Treasury Share Holdings With New Buybacks

TIPRANKS
·
Sep 26

GAO Sustains Protest over DHS CWMS 3.0 Award to WidePoint

Reuters
·
Sep 26

Worldwide Healthcare Trust Boosts Treasury Stock With Share Buyback

TIPRANKS
·
Sep 26

Reuters Next - Palantir Co-Founder Joe Lonsdale Says He Backs Amodei as the Right Leader for Anthropic

THOMSON REUTERS
·
Sep 26

Oil Prices Retreat as Markets Monitor US-Iran Diplomacy and Regional Tensions

Deep News
·
Sep 26

U.S. Stocks on the MOVEx-Microsoft, Nike, Nektar Therapeutics

Reuters
·
Sep 26

The Week in Breakingviews: Industry’s New Captains

Reuters
·
Sep 26

Bolloré Publishes Half‑Year 2026 Financial Report

TIPRANKS
·
Sep 26

BHP Group says Escondida activities have started to resume, Bloomberg reports

TIPRANKS
·
Sep 26

Acadia Pharmaceuticals' Risk-Reward Favorable After Remlifanserin Data, Deutsche Bank Says

MT Newswires Live
·
Sep 26

Regeneron Steps Into Obesity Drug Race With New Phase 1 Study

TIPRANKS
·
Sep 26

Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study

TIPRANKS
·
Sep 26

Pfizer’s RSV Revaccination Trial Targets Durable Booster Revenue in High‑Risk Adults

TIPRANKS
·
Sep 26

Argenx Advances Empasiprubart Into Phase 2 for Guillain-Barré: What Investors Should Watch

TIPRANKS
·
Sep 26

Arrowhead’s Plozasiran Trial Completion Marks a Key Catalyst in the Triglyceride Market

TIPRANKS
·
Sep 26